CQS Cayman’s Globus Medical GMED Stock Holding History

CQS Cayman’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.58M	Buy	+70,000	New	+$3.33M	0.16%	98

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

CQS Cayman's GMED Position: Q3 2019 in Review

CQS Cayman reduced its Globus Medical (GMED) stake by 67% in Q3 2019, selling an estimated $2.95M and leaving 30,500 shares worth $1.56M. The position accounts for 0.07% of the portfolio, ranked #130.

CQS Cayman first reported a position in GMED in Q1 2019 and has held it in 3 quarters since. The position peaked at $5.71M in Q1 2019. 268 funds tracked by Wall St. Rank hold GMED as of Q3 2019.

CQS Cayman held 30,500 shares of Globus Medical worth $1.56M as of Q3 2019.
CQS Cayman sold 62,000 Globus Medical shares in Q3 2019, an estimated $2.95M.
Globus Medical made up 0.07% of CQS Cayman's portfolio in Q3 2019, its #130 holding.
CQS Cayman first reported a position in Globus Medical in Q1 2019 and has held it in 3 quarters since.
CQS Cayman's Globus Medical position peaked at $5.71M in Q1 2019.
268 funds tracked by Wall St. Rank held Globus Medical as of Q3 2019.

Based on CQS Cayman's 13F filing for Q3 2019, filed 12 Nov 2019.